| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 06/01/2005 | EP1534672A1 Retinol derivatives, their use in the treatment of cancer and for potentiating the efficacy of other cytotoxic agents |
| 06/01/2005 | EP1534670A1 Enzyme activated self-immolative n-substituted nitrogen mustard prodrugs |
| 06/01/2005 | EP1534668A1 Crystalline solid form of (2s-5z)-2-amino-7-(ethanimidoylamino)-2-methylhept-5-enoic acid |
| 06/01/2005 | EP1534666A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex |
| 06/01/2005 | EP1534663A1 N-bridged selective androgen receptor modulators and methods of use thereof |
| 06/01/2005 | EP1534512A1 Coated particles, methods of making and using |
| 06/01/2005 | EP1534389A2 Pyrazolopyrimidines as kinase inhibitors |
| 06/01/2005 | EP1534346A2 Toluidine blue o drug substance and use thereof for in vivo staining and chemotherapeutic treatment of dysplastic tissues |
| 06/01/2005 | EP1534340A2 Cyclodextrin-based polymers for delivering the therapeutic agents covalently bound thereto |
| 06/01/2005 | EP1534338A1 Combination of vegf receptor tyrosine kinase inhibitors for treatment of cancer |
| 06/01/2005 | EP1534337A2 Ptk7 protein involvement in carcinoma |
| 06/01/2005 | EP1534332A2 Antibodies and uses thereof |
| 06/01/2005 | EP1534331A2 Membrane associated tumor endothelium markers |
| 06/01/2005 | EP1534330A1 Whole bacterial cells as immune modulator |
| 06/01/2005 | EP1534324A2 Tumor specific oligosaccharide epitopes and use thereof |
| 06/01/2005 | EP1534322A1 Minibrain homologous proteins involved in the regulation of energy homeostasis |
| 06/01/2005 | EP1534312A2 Intrathecal and intratumoral superantigens to treat malignant disease |
| 06/01/2005 | EP1534308A2 Peptides with growth inhibitory action |
| 06/01/2005 | EP1534300A2 3, 10, and 12a substituted tetracycline compounds |
| 06/01/2005 | EP1534299A2 Methods for treating psychosis associated with interferon-alpha therapy |
| 06/01/2005 | EP1534290A2 Novel inhibitors of kinases |
| 06/01/2005 | EP1534289A1 Adenosine a2a receptor antagonists for treating restless legs syndrome or related disorders |
| 06/01/2005 | EP1534287A1 Combination of zd6474, an inhibitor of the vascular endothelial growth factor receptor, with radiotherapy in the treatment of cancer |
| 06/01/2005 | EP1534284A2 Amino-substituted sulfonanilides and derivatives thereof for treating proliferative disorders |
| 06/01/2005 | EP1534283A1 Formulation of liposomal derivatives of phenylalanine |
| 06/01/2005 | EP1534281A1 N-sulfonylpiperidines as metalloproteinase inhibitors (tace) |
| 06/01/2005 | EP1534279A2 Prenylation inhibitors containing dimethyl-cyclobutane and methods of their synthesis and use |
| 06/01/2005 | EP1534278A2 Nitrosated proton pump inhibitors, compositions and methods of use |
| 06/01/2005 | EP1534271A1 Antitumor compound and therapeutic uses thereof |
| 06/01/2005 | EP1534265A1 Combination of an aromatase inhibitor with a bisphosphonate |
| 06/01/2005 | EP1534263A2 Novel compounds, pharmaceutical compositions containing same, and methods of use for same |
| 06/01/2005 | EP1534262A1 Combination of chemotherapeutic drugs for increasing antitumor activity |
| 06/01/2005 | EP1534260A2 Perfluorinated fatty acids for the treatment of obesity, diabetes, hyperlipidaemia, cancer and inflammation |
| 06/01/2005 | EP1534250A2 Electrospun amorphous pharmaceutical compositions |
| 06/01/2005 | EP1534248A1 Lasofoxifene tablet and its coating |
| 06/01/2005 | EP1534242A2 Buccal, polar or non-polar spray or capsule containing drugs for treating disorders of the gastrointestinal tract or urinary tract |
| 06/01/2005 | EP1453820B1 Substituted 6h-dibenzo[c,h]chromenes as estrogenic agents |
| 06/01/2005 | EP1416936B1 Thiopyrane-4-ones as dna protein kinase inhibitors |
| 06/01/2005 | EP1404330B1 Substituted 8-arylquinoline pde4 inhibitors |
| 06/01/2005 | EP1383539A4 Anticancer drug-chitosan complex forming self-aggregates and preparation method thereof |
| 06/01/2005 | EP1345902B1 Substituted heterocyclo-norbornylamine derivatives, method for producing the same, their use as medicament or diagnostic agent and medicament containing the same |
| 06/01/2005 | EP1296985B1 Heteropolycyclic inhibitors |
| 06/01/2005 | EP1248761A4 Compounds which mimic the chemical and biological properties of discodermolide |
| 06/01/2005 | EP1233951B1 3,4-dihydro-(1h)quinazolin-2-one compounds as csbp/p38 kinase inhibitors |
| 06/01/2005 | EP1178977B1 Ion channel modulating agents |
| 06/01/2005 | EP1062210B1 1,2-diazepane derivatives as interleukin-1beta converting enzyme inhibitors |
| 06/01/2005 | EP0906433B1 Protein tyrosine phosphatases of hematopoietic cells |
| 06/01/2005 | CN1623001A System for monitoring bacterial tumor treatment |
| 06/01/2005 | CN1622995A Receptor nucleic acids and polypeptides |
| 06/01/2005 | CN1622992A Synthetic peptides and methods for treating cancer invasion and metastasis |
| 06/01/2005 | CN1622958A Epitope regions of a thyrotrophin (TSH) receptor, uses thereof and antibodies thereto |
| 06/01/2005 | CN1622957A IFNAR2 mutants, their production and use |
| 06/01/2005 | CN1622956A Cytotoxic cyplasin of the sea hare, aplysia punctata, cdna cloning and expression of bioreactive recombinants |
| 06/01/2005 | CN1622941A Glutaminyl based DPIV inhibitors |
| 06/01/2005 | CN1622939A 9-aminoacridine derivatives and process for the preparation thereof |
| 06/01/2005 | CN1622830A Peptide-based compounds |
| 06/01/2005 | CN1622829A Solidified tissue immunological adjuvant |
| 06/01/2005 | CN1622814A Use of antitumor indolopyrrolocarbazole derivative and other anticancer agent in combination |
| 06/01/2005 | CN1622808A Treatment of gastrointestinal stromal tumors |
| 06/01/2005 | CN1622805A Combinations comprising an antidiarrheal agent and an epothilone or an epothilone derivative |
| 06/01/2005 | CN1622754A Novel immune effect compound |
| 06/01/2005 | CN1621414A Antigenic determinant polypeptide of human tumor-testis antigen HCA587 and use thereof |
| 06/01/2005 | CN1621093A Construction of 5-fluorouracil chitosan minipill for filling to inside of the bladder to treat bladder cancer |
| 06/01/2005 | CN1621092A Folic acid receptor targeted liposome medicine carrier, its preparation and application |
| 06/01/2005 | CN1621047A Medicine for treating hysteromyoma |
| 06/01/2005 | CN1621042A Freeze dried powder injection of cytarabine and its preparation process |
| 06/01/2005 | CN1621032A Application of microcapsule composition infusing to abdomen cavity for preventing carcinomatosis |
| 06/01/2005 | CN1204258C Component of bromelain |
| 06/01/2005 | CN1204238C Kenrel oil composite extracted from plant kernel and its extraction process and medicinal preparation |
| 06/01/2005 | CN1204146C Method for preparing alpha-fetoglobulin transspecific factor |
| 06/01/2005 | CN1204145C Preparation of human vasal endothelial cell growth inhibitor and its application in tumor angiogenesis resisting treatment |
| 06/01/2005 | CN1204138C Pyrazolo [4, 3-d] pyrimidine derivs. |
| 06/01/2005 | CN1203899C Compounds with chelation affinity and selectivity for first transition series elements, and their use in medical therapy |
| 06/01/2005 | CN1203898C Perfluoroalkyl-containing metal complexes, its preparing method and use in NMR diagnostics |
| 06/01/2005 | CN1203894C Anti-cancer medicine composition |
| 06/01/2005 | CN1203893C Anti-cancer medicine composition |
| 05/31/2005 | US6900344 Method of preparing alkylated salicylamides via a dicarboxylate intermediate |
| 05/31/2005 | US6900339 Collecting bryostatin from a plankton larvae, by stressing, exudation, isolation, extraction, purification; use as antitumor agents, anticarcinogenic agents, leukemia |
| 05/31/2005 | US6900334 Antiallergens; autoimmune diseases |
| 05/31/2005 | US6900318 1,4,5,6-tetrahydropyrimidine derivative as a vitronectin inhibitor |
| 05/31/2005 | US6900243 Phenylheteroalkylamine derivatives |
| 05/31/2005 | US6900242 Compound for use in the treatment of cancer and prevention of infections |
| 05/31/2005 | US6900235 Anticancer agents; viricides |
| 05/31/2005 | US6900232 For therapy of tumor metastasis, solid tumor growth (neoplasia), osteoporosis, Paget's disease, humoral hypercalcemia of malignancy, osteopenia, angiogenesis, including tumor angiogenesis and lymphangiogenesis |
| 05/31/2005 | US6900230 Heterocyclo-alkylsulfonyl pyrazoles as anti-inflammatory/analgesic agents |
| 05/31/2005 | US6900221 Crystalline polymorph of erlotinib hydrochloride; synthesis; treating cancer |
| 05/31/2005 | US6900216 Psychological disorders; antidepressants; brain diosrders; anticonvulsants |
| 05/31/2005 | US6900214 Cyano-substituted dihydropyrimidine compounds and their use to treat diseases |
| 05/31/2005 | US6900205 Antidiabetic agents |
| 05/31/2005 | US6900201 N-substituted-heteroaryloxy-aryl-spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 05/31/2005 | US6900185 Genetic engineering; binding Dna to apolipoprotein ligand; antitumor agents |
| 05/31/2005 | US6900160 Triazolo-epothilones |
| 05/31/2005 | US6900049 Adenovirus vectors containing cell status-specific response elements and methods of use thereof |
| 05/31/2005 | US6900043 Phosphatases which activate map kinase pathways |
| 05/31/2005 | US6900032 Human PTTG polypeptide and method for producing it |
| 05/31/2005 | US6900027 Preparing biopsy of tumorous tissue and monitoring chemosensitivity to anticarcinogenic agents; antitumor agents |
| 05/31/2005 | US6899900 Composition of multipurpose high functional alkaline solution composition, preparation thereof, and for the use of nonspecific immunostimulator |
| 05/31/2005 | US6899867 Hydrolytically degradable carbamate derivatives of poly(ethylene glycol) |
| 05/31/2005 | US6899864 Kit and method for targeting of a diagnostic or therapeutic agent to target site in mammal having a pathological condition |
| 05/31/2005 | US6899863 Method for preparing membrane vesicles |